FOXP1 and non-small cell lung carcinoma: Some studies have found that circ FOXP1 was significantly overexpressed in the serum of NSCLC patients [159], and the down-regulation of circ FOXP1 can inhibit the proliferation of lung cancer cells [160, 161].